 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1761 - 1770 of 2187:
Next president will want FDA to regulate tobacco
House panel is in the middle of deliberations on legislation to give the federal Food and Drug Administration the power to regulate tobacco products....
No Child's Play - FDA Panel Recommends Stronger Warning To Prevent Pediatric Use Of Provigil [CEPH]
Cephalon's sleep disorder drug Provigil, has once again come under the scanner of the U.S. Food and Drug Administration. Wednesday, an FDA panel said ...
No Love for Antibiotics From the FDA
Wyeth was on a roll with the FDA, getting three approvals in the first four months of the year, but its latest letter from the FDA didn't quite have ...
No More Need to Inject Insulin it can be Inhaled
Diabetic pateints have to inject themselves with insulin mealtime to help control their blood sugar levels. But a new, palm-size device may let them ...
No Surprises In FDA's Draft Stent Guidelines
The new U.S. Food and Drug Administration draft guidelines for drug-coated stent heart devices didn't include any surprises for Xtent Inc. (XTNT), wh...
Northfield Labs' blood substitute Failed to get FDA's Approval
All hopes of Northfield Laboratories Inc. of winning U.S. approval of a blood substitute for use in trauma patients came to an end when the Food and D...
Notice against sterilization device issued by FDA
The Food and Drug Administration (FDA) has questioned the safety and effectiveness of the widely used surgical sterilizer tool System 1 Processor (SS1...
NovaDel Pharma Receives FDA Approval of Zolpimist
NovaDel Pharma Inc. (AMEX: NVD), a pharmaceutical company based in the borough, today announced that the Food and Drug Administration has approved its...
Novartis' Myfortic poses fetal risks--FDA
The U.S. Food and Drug Administration said on Tuesday that Novartis AG's organ rejection drug, Myfortic, increases risk of first-trimester miscarriage...
Novartis' Osteoarthritis Pain Treatment Voltaren Gel Gets FDA Approval
Swiss healthcare company Novartis AG (NVS) said its Voltaren Gel has received US Food and Drug Administration approval as the first approved topical p... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |